A patient calls NHS 111 with a sore throat, gets told to go to the pharmacy, arrives at the counter and the pharmacist's first question is: "Did 111 send a referral, or are you walking in?" The answer determines whether the consultation is funded as a CPCS contact, a Pharmacy First consultation, a NUMSAS supply, or a private over-the-counter sale.
The route the patient travelled to the pharmacy door changes the consultation, the funding and — increasingly — the documentation. This piece sets out how the three NHS 111-to-pharmacy services interact in 2026, and the common misunderstandings that cause patients to be sent to the wrong place.
The three pathways at a glance
| Service | What 111 routes through it | Pharmacy action |
|---|---|---|
| Community Pharmacist Consultation Service (CPCS) | Minor illness symptom referrals from NHS 111, NHS 111 online, and GP practices | Structured consultation; supply OTC if appropriate; refer onwards if needed |
| Pharmacy First | Seven specific clinical pathways (acute otitis media, impetigo, infected insect bite, sinusitis, sore throat, UTI in women, shingles) | Consultation under PGD; supply prescription medicine if criteria met |
| NUMSAS — NHS Urgent Medicine Supply Advanced Service | Patients who have run out of regular medicines and need an urgent supply | Emergency supply of regular medicine; pharmacist-led decision |
CPCS and NUMSAS are advanced services delivered under the community pharmacy contractual framework. Pharmacy First is the clinical service introduced in January 2024 that allows community pharmacists to supply prescription-only medicines for the seven listed conditions without a GP appointment.
A patient may move between pathways during a single visit. A NUMSAS patient who runs out of antibiotics may be re-routed to a Pharmacy First sore throat or UTI pathway if eligible. A CPCS minor illness referral for "earache" may turn out to meet Pharmacy First otitis media criteria.
What changed in 2026
The Pharmacy First service is now in its third year of operation, and the NHS 111 routing logic has been progressively tuned. The most consequential changes from a pharmacy operations perspective are:
- NHS 111 online directly offers Pharmacy First-eligible self-referral for the seven clinical pathway conditions. Patients who answer the symptom assessment in a way that maps to a pathway are sent to a pharmacy with a referral attached.
- Walk-in Pharmacy First consultations are funded equivalently to NHS 111 referrals. The "must come from 111" misconception is one of the most common reasons patients are turned away unnecessarily.
- CPCS minor illness referrals are increasingly automated — the NHS 111 clinician sends a structured electronic referral to the patient's nominated pharmacy, with a callback expectation rather than a same-day attendance window.
- NUMSAS emergency supply is unchanged in principle but the documentation expectation has tightened; the 30-day supply rule and the prescriber notification step are both audited.
The common misunderstandings to avoid
Five misunderstandings recur and are worth correcting at the counter:
| Misunderstanding | Reality |
|---|---|
| "Pharmacy First only applies if 111 referred me" | False — patients can self-present for any of the seven Pharmacy First conditions and the consultation is funded the same way |
| "111 always sends an electronic referral" | Not always — verbal referrals over the phone happen, and the pharmacy may need to ring back to confirm |
| "I have to use my registered pharmacy" | False for CPCS, NUMSAS and Pharmacy First — any participating pharmacy can deliver the service |
| "Pharmacy First gives me antibiotics for anything" | False — only seven specific conditions, with strict eligibility criteria including age limits |
| "111 should send me to a pharmacy for chest pain" | Never — chest pain, severe shortness of breath and possible stroke are 999 referrals, not pharmacy referrals |
The age-limit point matters. Pharmacy First's seven pathways have specific eligibility — sore throat is for ages 5+, otitis media is for ages 1–17, sinusitis is for ages 12+, shingles is for adults, UTI is for non-pregnant women aged 16–64, impetigo is for ages 1+, infected insect bite is for ages 1+. A patient sent for "Pharmacy First" who falls outside these criteria needs an alternative route.
How CPCS and Pharmacy First interact in a single consultation
The cleanest way to think about it is that CPCS is the front door and Pharmacy First is one of several back doors. A patient referred under CPCS for "earache" might end up:
- Receiving Pharmacy First treatment for acute otitis media, if they meet the clinical criteria
- Receiving over-the-counter analgesia and self-care advice if their presentation is non-bacterial
- Being onward-referred to general practice or to A&E if red-flag symptoms appear during the consultation
Each of these is a legitimate CPCS outcome. The pharmacy does not need to convert every CPCS referral into a Pharmacy First supply — and is not paid more for doing so. The clinical decision determines the route.
When NUMSAS is the right answer
NUMSAS exists for one scenario: a patient who has run out of a regularly-prescribed medicine and cannot reasonably wait for the GP. The pharmacy's job under NUMSAS is to:
- Confirm the medicine is one the patient has been taking regularly
- Confirm the supply does not exceed the lesser of 30 days or one cycle (with shorter limits for controlled drugs and inhalers)
- Document the consultation and notify the patient's prescriber
NUMSAS is not a route for a new clinical problem ("I haven't seen a GP about this rash but I'd like something for it") and is not a route for first-time supplies. A patient in either scenario should be re-routed to Pharmacy First (if eligible), CPCS (for minor illness assessment) or general practice.
Practical operations notes
A few points worth standardising across the pharmacy team:
- Check the NHS 111 referral platform every shift. Electronic referrals can sit unactioned if no one logs in. Many pharmacies have configured an audible alert.
- Treat walk-in Pharmacy First-eligible patients as Pharmacy First, not as private OTC sales. The patient gets the same product cheaper or free; the pharmacy gets the consultation fee; the data flows into the national service evaluation.
- Document carefully. All three services have documentation requirements that are audited; the click-counts add up over a busy day but the post-hoc reconstruction work is significantly worse.
- Refer onwards confidently. A pharmacist who escalates a possible meningitis presentation to A&E is doing the system a service, not a disservice. The data on safe-not-to-treat decisions is becoming a recognised quality metric.
Where this fits in the pharmacy workforce
Pharmacy First and CPCS together represent the largest expansion of pharmacist clinical scope in a generation. According to PharmSee's vacancy tracker, the UK pharmacy sector carried more than 1,700 active postings in mid-April 2026, with a growing share of NHS and PCN roles explicitly framed around urgent care and clinical service delivery. Find a participating pharmacy via the PharmSee pharmacy locator; browse current openings on the PharmSee jobs feed.
Caveats
This article summarises NHS England, Community Pharmacy England and NHS guidance current at publication. Service specifications are updated; the contractual position for any individual pharmacy is governed by the live NHS England documentation, not by this summary. Individual patient eligibility for any of the three services is a clinical and contractual decision made at the counter, not a list-checked outcome.
Sources
- NHS England — Community Pharmacy services and Pharmacy First
- Community Pharmacy England — Service specifications
- NHS — When to use 111
- NHS England — CPCS and NUMSAS service specifications
workforce news